JP2019528736A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528736A5
JP2019528736A5 JP2019514770A JP2019514770A JP2019528736A5 JP 2019528736 A5 JP2019528736 A5 JP 2019528736A5 JP 2019514770 A JP2019514770 A JP 2019514770A JP 2019514770 A JP2019514770 A JP 2019514770A JP 2019528736 A5 JP2019528736 A5 JP 2019528736A5
Authority
JP
Japan
Prior art keywords
protein
mir
composition
seq
modrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019514770A
Other languages
English (en)
Japanese (ja)
Other versions
JP7432362B2 (ja
JP2019528736A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/052035 external-priority patent/WO2018053414A1/en
Publication of JP2019528736A publication Critical patent/JP2019528736A/ja
Publication of JP2019528736A5 publication Critical patent/JP2019528736A5/ja
Priority to JP2023093720A priority Critical patent/JP2023123520A/ja
Application granted granted Critical
Publication of JP7432362B2 publication Critical patent/JP7432362B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019514770A 2016-09-16 2017-09-18 modRNAの細胞特異的発現 Active JP7432362B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023093720A JP2023123520A (ja) 2016-09-16 2023-06-07 modRNAの細胞特異的発現

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662395701P 2016-09-16 2016-09-16
US62/395,701 2016-09-16
PCT/US2017/052035 WO2018053414A1 (en) 2016-09-16 2017-09-18 Cell-specific expression of modrna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023093720A Division JP2023123520A (ja) 2016-09-16 2023-06-07 modRNAの細胞特異的発現

Publications (3)

Publication Number Publication Date
JP2019528736A JP2019528736A (ja) 2019-10-17
JP2019528736A5 true JP2019528736A5 (cg-RX-API-DMAC10.html) 2020-11-12
JP7432362B2 JP7432362B2 (ja) 2024-02-16

Family

ID=61619271

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019514770A Active JP7432362B2 (ja) 2016-09-16 2017-09-18 modRNAの細胞特異的発現
JP2023093720A Pending JP2023123520A (ja) 2016-09-16 2023-06-07 modRNAの細胞特異的発現

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023093720A Pending JP2023123520A (ja) 2016-09-16 2023-06-07 modRNAの細胞特異的発現

Country Status (9)

Country Link
US (3) US11299749B2 (cg-RX-API-DMAC10.html)
EP (2) EP3512567B1 (cg-RX-API-DMAC10.html)
JP (2) JP7432362B2 (cg-RX-API-DMAC10.html)
CN (1) CN110177578B (cg-RX-API-DMAC10.html)
AU (2) AU2017326535B2 (cg-RX-API-DMAC10.html)
BR (1) BR112019005144A2 (cg-RX-API-DMAC10.html)
CA (1) CA3036710A1 (cg-RX-API-DMAC10.html)
ES (1) ES2967788T3 (cg-RX-API-DMAC10.html)
WO (1) WO2018053414A1 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017326535B2 (en) * 2016-09-16 2023-08-24 Icahn School Of Medicine At Mount Sinai Cell-specific expression of modrna
CN111971392A (zh) * 2018-03-30 2020-11-20 国立大学法人京都大学 细胞的制造方法
EP4010481A4 (en) 2019-08-09 2023-09-20 Nutcracker Therapeutics, Inc. MICROFLUIDIC DEVICE AND METHODS OF USE
US12606822B2 (en) 2019-11-07 2026-04-21 Icahn School Of Medicine At Mount Sinai Synthetic modified RNA and uses thereof
US20220347204A1 (en) * 2019-11-11 2022-11-03 Icahn School Of Medicine At Mount Sinai Gene delivery systems for treatment of heart failure
EP4351623B1 (en) 2021-06-09 2026-08-05 Icahn School of Medicine at Mount Sinai Gene combination as a broad spectrum antiviral
US20240384277A1 (en) * 2021-06-15 2024-11-21 Modernatx, Inc. Engineered polynucleotides for cell-type or microenvironment-specific expression
CN114085834A (zh) * 2021-11-16 2022-02-25 珠海中科先进技术研究院有限公司 一种癌细胞导向电路组及应用
US20250290056A1 (en) * 2022-04-27 2025-09-18 The Penn State Research Foundation Modrna-based cas endonuclease and base editor and uses thereof
US20230364267A1 (en) * 2022-05-13 2023-11-16 The Uab Research Foundation Pre-clinical modified rna approaches used in large animals for muscle and vascular regeneration
EP4282963A1 (en) * 2022-05-23 2023-11-29 Eberhard Karls Universität Tübingen, Medizinische Fakultät Nucleic acid modified biological cell with expansion-dependent gene expression
WO2024015729A1 (en) * 2022-07-11 2024-01-18 Icahn School Of Medicine At Mount Sinai Regulatory system for expression of a gene of interest in a target cell and method of use thereof
EP4562163A1 (en) * 2022-07-26 2025-06-04 ModernaTX, Inc. Engineered polynucleotides for temporal control of expression
CN116785501A (zh) * 2022-08-04 2023-09-22 上海交通大学医学院附属上海儿童医学中心 促进心脏组织修复的modRNA转染改造的细胞及其应用
WO2024151975A1 (en) 2023-01-13 2024-07-18 Igor Lednev Detecting degradation of a polynucleotide by raman spectroscopy
CN119120571B (zh) * 2024-09-11 2026-03-17 武汉科技大学 一种治疗hiv感染的靶向外泌体嵌合抗原受体分子的构建及其应用
WO2026107144A1 (en) 2024-11-14 2026-05-21 Icahn School Of Medicine At Mount Sinai Rna sequence for expressing protein in cardiomyocytes
WO2026147861A1 (en) 2024-12-30 2026-07-09 Icahn School Of Medicine At Mount Sinai System for gene expression in colon cancer cells and method of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331526T2 (de) 1992-11-18 2002-10-24 Arch Development Corp., Chicago Adenovirus gelenkter gen-transfer zum herz- und glatten vaskularen muskel
US20090005336A1 (en) * 2007-05-08 2009-01-01 Zhiguo Wang Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
ES2769129T3 (es) * 2009-12-07 2020-06-24 Univ Pennsylvania Preparaciones de ARN que comprenden ARN modificado purificado para reprogramar células
US9458509B2 (en) * 2010-07-22 2016-10-04 President And Fellows Of Harvard College Multiple input biologic classifier circuits for cells
US10086043B2 (en) 2011-04-03 2018-10-02 The General Hospital Corporation Efficient protein expression in vivo using modified RNA (MOD-RNA)
EP2584040A1 (en) * 2011-10-17 2013-04-24 Pharmahungary 2000 Kft. Compounds for treatment of ischemic injury
CA2915627A1 (en) * 2012-06-15 2013-12-19 The General Hospital Corporation Inhibitors of micrornas that regulate production of atrial natriuretic peptide (anp) as therapeutics and uses thereof
WO2014093574A1 (en) * 2012-12-13 2014-06-19 Moderna Therapeutics, Inc. Modified polynucleotides for altering cell phenotype
US10538740B2 (en) 2014-03-20 2020-01-21 Kyoto University Method for sorting cardiomyocytes
WO2016040395A1 (en) * 2014-09-08 2016-03-17 Massachusetts Institute Of Technology Rna-based logic circuits with rna binding proteins, aptamers and small molecules
AU2017326535B2 (en) * 2016-09-16 2023-08-24 Icahn School Of Medicine At Mount Sinai Cell-specific expression of modrna

Similar Documents

Publication Publication Date Title
US20250154523A1 (en) CELL-SPECIFIC EXPRESSION OF modRNA
Gabisonia et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs
Günthel et al. Development, proliferation, and growth of the mammalian heart
Leone et al. Advances in heart regeneration based on cardiomyocyte proliferation and regenerative potential of binucleated cardiomyocytes and polyploidization
Vaughan et al. Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma
Briggs et al. Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects
KR101478869B1 (ko) 마이크로rna를 이용한 조절을 통한 암 특이적 유전자 치료제
US20150164957A1 (en) Conversion of cardiomyocytes into fast conducting cardiomyocytes or slow conducting nodal cells
Sun et al. Transient overexpression of hPKM2 in porcine cardiomyocytes prevents heart failure after myocardial infarction
CN102533834A (zh) 一种在体无创监测microRNA表达的双模态成像报告基因的方法
CN102839187A (zh) miR-29吸收序列、吸收载体及其用途
Vilaboa et al. Gene switches for deliberate regulation of transgene expression: recent advances in system development and uses
JP7670335B2 (ja) 心不全に応答するエンハンサーポリヌクレオチド、及び前記エンハンサーポリヌクレオチドを含む発現ベクター
WO2015127527A1 (en) Co-expression of magnetotactic bacterial genes and genes encoding iron handling proteins in cells
Velayutham Mechanisms of cardiomyocyte cell cycle arrest and maturation in postnatal rodents and swine
Choudhury et al. YIA1 TBX18 Biopacemaking Improves Beating Rate and Alters Gene Expression in Bradycardic Subsidiary Right Atrial Pacemaker Tissue
ES2774486T3 (es) MicroARN para el tratamiento de enfermedades cardíacas
CN111118008A (zh) Mcl1基因的3’-UTR序列及其应用
Stamatoyannopoulos Large-scale analysis of erythroid chromatin structure
Kikuchi et al. S19-04 Cardiac regeneration in the zebrafish model system
Mofid et al. MINICIRCLE-S100A6 GENE THERAPY BY ULTRASOUND-TARGETED MICROBUBBLE DESTRUCTION FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION-REPERFUSION IN RATS
Tsoporis et al. THE INFUSION OF MESENCHYMAL STROMAL CELLS INCREASES MYOCARDIAL S100A6 AND LIMITS ADVERSE LEFT VENTRICULAR REMODELING POST MYOCARDIAL INFARCTION
Zakharkin et al. OPEN Silencing miR-370-3p rescues funny current and sinus node function in heart failure
Joshi LIN28/let-7 Axis as a Regulator of Myocardial Ischemic Injury
Jayawardena et al. MicroRNA Induced Cardiac Reprogramming In Vivo